Miscellaneous Vascular Diseases

[1]  A. Vaglio,et al.  Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): evolutions in classification, etiopathogenesis, assessment and management , 2014, Current opinion in rheumatology.

[2]  A. Ducros Reversible cerebral vasoconstriction syndrome. , 2014, Handbook of clinical neurology.

[3]  S. Porter,et al.  Wegener's granulomatosis: a review of clinical features and an update in diagnosis and treatment. , 2013, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[4]  Y. Tüzün,et al.  Behçet's syndrome: facts and controversies. , 2013, Clinics in dermatology.

[5]  W. Schmidt Imaging in vasculitis. , 2013, Best practice & research. Clinical rheumatology.

[6]  G. Deuschl,et al.  Acute Cerebrovascular Disease in the Young: The Stroke in Young Fabry Patients Study , 2013, Stroke.

[7]  M. van Buchem,et al.  Neuropsychiatric manifestations in patients with systemic lupus erythematosus: epidemiology and radiology pointing to an immune-mediated cause , 2012, Annals of the rheumatic diseases.

[8]  M. Gonzalez-gay,et al.  Biopsy-proven giant cell arteritis patients with coronary artery disease have increased risk of aortic aneurysmal disease and arterial thrombosis. , 2013, Clinical and experimental rheumatology.

[9]  L. Mouthon,et al.  Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. , 2013, Arthritis and rheumatism.

[10]  D. Gladman,et al.  Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort. , 2012, Seminars in arthritis and rheumatism.

[11]  Edward R. Smith,et al.  Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. A review. , 2012, Journal of neurosurgery. Pediatrics.

[12]  G. Hunder,et al.  Primary central nervous system vasculitis: pathology and mechanisms , 2012, Acta Neuropathologica.

[13]  D. Mikulis,et al.  Vessel Wall MRI to Differentiate Between Reversible Cerebral Vasoconstriction Syndrome and Central Nervous System Vasculitis: Preliminary Results , 2012, Stroke.

[14]  Marcelo Sánchez,et al.  Large vessel involvement in biopsy-proven giant cell arteritis: prospective study in 40 newly diagnosed patients using CT angiography , 2012, Annals of the rheumatic diseases.

[15]  H. Huseinagić,et al.  Wegener's granulomatosis of the paranasal sinuses with orbital and central nervous system involvement-diagnostic imaging. , 2011, Acta neurologica Belgica.

[16]  A. Popescu,et al.  Neuropsychiatric Systemic Lupus Erythematosus , 2011, Current neuropharmacology.

[17]  M. Boaz,et al.  Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. , 2011, Seminars in arthritis and rheumatism.

[18]  J. Gutierrez,et al.  HIV/AIDS Patients with HIV Vasculopathy and VZV Vasculitis , 2011, Clinical Neuroradiology.

[19]  Tracey A. Cho,et al.  Cerebrovascular disease in central nervous system infections. , 2011, Seminars in neurology.

[20]  A. Mahr,et al.  Epidemiology and etiology of wegener granulomatosis, microscopic polyangiitis, churg-strauss syndrome and goodpasture syndrome: vasculitides with frequent lung involvement. , 2011, Seminars in respiratory and critical care medicine.

[21]  M. van Buchem,et al.  Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. , 2011, Arthritis and rheumatism.

[22]  R. Porcher,et al.  Hemorrhagic Manifestations of Reversible Cerebral Vasoconstriction Syndrome: Frequency, Features, and Risk Factors , 2010, Stroke.

[23]  L. Mouthon,et al.  Pathogenesis of giant cell arteritis: More than just an inflammatory condition? , 2010, Autoimmunity reviews.

[24]  C. van Broeckhoven,et al.  Belgian Fabry Study: Prevalence of Fabry Disease in a Cohort of 1000 Young Patients With Cerebrovascular Disease , 2010, Stroke.

[25]  J. Epplen,et al.  Recent progress in the genetics of Wegener's granulomatosis and Churg–Strauss syndrome , 2010, Current opinion in rheumatology.

[26]  A. Bagga,et al.  Large vessel vasculitis , 2009, Pediatric Nephrology.

[27]  Javier Martín,et al.  Epidemiology of giant cell arteritis and polymyalgia rheumatica. , 2009, Arthritis and rheumatism.

[28]  R. Cohrs,et al.  Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment , 2009, The Lancet Neurology.

[29]  Greg Zaharchuk,et al.  Quantitative hemodynamic studies in moyamoya disease , 2009 .

[30]  B. Bendok,et al.  Moyamoya disease: a summary. , 2009, Neurosurgical focus.

[31]  D. Mikulis,et al.  The contribution of imaging in diagnosis, preoperative assessment, and follow-up of moyamoya disease: a review. , 2009, Neurosurgical focus.

[32]  P. Stoeter,et al.  Diagnostic utility of different MRI and MR angiography measures in Fabry disease , 2009, Neurology.

[33]  H. S. Kim,et al.  Quantitative Cerebrovascular Reserve Measured by Acetazolamide-Challenged Dynamic CT Perfusion in Ischemic Adult Moyamoya Disease: Initial Experience with Angiographic Correlation , 2008, American Journal of Neuroradiology.

[34]  G. Paludetti,et al.  Wegener’s granulomatosis: an update on diagnosis and therapy , 2008, Expert review of clinical immunology.

[35]  W. Bartynski Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema , 2008, American Journal of Neuroradiology.

[36]  W. Bartynski Posterior Reversible Encephalopathy Syndrome, Part 1: Fundamental Imaging and Clinical Features , 2008, American Journal of Neuroradiology.

[37]  J. Safdieh,et al.  The varicella zoster virus vasculopathies , 2008, Neurology.

[38]  J. Boardman,et al.  Catheter Angiography, MR Angiography, and MR Perfusion in Posterior Reversible Encephalopathy Syndrome , 2008, American Journal of Neuroradiology.

[39]  Edward R. Smith,et al.  Progression of disease in unilateral moyamoya syndrome. , 2008, Neurosurgical focus.

[40]  S. Kuroda,et al.  Novel epidemiological features of moyamoya disease , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

[41]  R. Porcher,et al.  The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. , 2007, Brain : a journal of neurology.

[42]  F. Cendes,et al.  Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus , 2007, Lupus.

[43]  S. Weigand,et al.  Primary central nervous system vasculitis: analysis of 101 patients , 2007, Annals of neurology.

[44]  M. Langer,et al.  Diagnostic Value of High-Resolution MR Imaging in Giant Cell Arteritis , 2007, American Journal of Neuroradiology.

[45]  S. Uchiyama,et al.  THE CHARACTERIZATION OF CEREBROSPINAL FLUID AND SERUM CYTOKINES IN PATIENTS WITH KAWASAKI DISEASE , 2007, The Pediatric infectious disease journal.

[46]  R. Schiffmann,et al.  The cerebral vasculopathy of Fabry disease , 2007, Journal of the Neurological Sciences.

[47]  A. Singhal,et al.  Narrative Review: Reversible Cerebral Vasoconstriction Syndromes , 2007, Annals of Internal Medicine.

[48]  M. Segelmark,et al.  The challenge of managing patients with polyarteritis nodosa , 2007, Current opinion in rheumatology.

[49]  P. Phillips,et al.  Pituitary involvement in Wegener’s granulomatosis , 2007, Pituitary.

[50]  H. Chabriat,et al.  Cortical Neuronal Apoptosis in CADASIL , 2006, Stroke.

[51]  K. Nozaki,et al.  Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[52]  A. Parra,et al.  CT and CT‐Perfusion Findings of Reversible Leukoencephalopathy During Triple‐H Therapy for Symptomatic Subarachnoid Hemorrhage‐Related Vasospasm , 2006, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[53]  Matthias J. Müller,et al.  Pattern of microstructural brain tissue alterations in Fabry disease , 2006, Journal of Neurology.

[54]  H. Chabriat,et al.  Dilation of Virchow‐Robin spaces in CADASIL , 2006, European journal of neurology.

[55]  R. Seror,et al.  Central Nervous System Involvement in Wegener Granulomatosis , 2006, Medicine.

[56]  E. Kotter,et al.  Sinonasal Computed Tomography in Patients With Wegener's Granulomatosis , 2006, Journal of computer assisted tomography.

[57]  J. Epplen,et al.  The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. , 2005, Arthritis and rheumatism.

[58]  David J Mikulis,et al.  Preoperative and postoperative mapping of cerebrovascular reactivity in moyamoya disease by using blood oxygen level-dependent magnetic resonance imaging. , 2005, Journal of neurosurgery.

[59]  M. Hartmann,et al.  Cerebrovascular manifestations of Takayasu arteritis in Europe. , 2005, Rheumatology.

[60]  D. Bluemke,et al.  Delayed contrast-enhanced MRI of the aortic wall in Takayasu's arteritis: initial experience. , 2005, AJR. American journal of roentgenology.

[61]  K Ohno,et al.  Severe haemodynamic stress in selected subtypes of patients with moyamoya disease: a positron emission tomography study , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[62]  K. Nozaki,et al.  Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study. , 2005, Journal of neurosurgery.

[63]  K. Arita,et al.  CT perfusion imaging for childhood moyamoya disease before and after surgical revascularization , 2005, Acta Neurochirurgica.

[64]  Christian Schindler,et al.  The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[65]  M. Dichgans,et al.  Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients. , 2004, Brain : a journal of neurology.

[66]  H. Petropoulos,et al.  Multisequence magnetic resonance imaging study of neuropsychiatric systemic lupus erythematosus. , 2004, Arthritis and rheumatism.

[67]  M. Brys,et al.  Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease , 2004, Journal of Neurology.

[68]  M. Ferrari,et al.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: MR imaging findings at different ages--3rd-6th decades. , 2003, Radiology.

[69]  K. Sasai,et al.  MR features of diseases involving bilateral middle cerebellar peduncles. , 2003, AJNR. American journal of neuroradiology.

[70]  R. Schiffmann,et al.  Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. , 2003, AJNR. American journal of neuroradiology.

[71]  H. Pfister,et al.  Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. , 2003, Brain : a journal of neurology.

[72]  K. Arima,et al.  Arterial Changes in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) in Relation to Pathogenesis of Diffuse Myelin Loss of Cerebral White Matter: Examination of Cerebral Medullary Arteries by Reconstruction of Serial Sections of an Autopsy Case , 2002, Stroke.

[73]  Nils Peters,et al.  Cerebral Microbleeds in CADASIL: A Gradient-Echo Magnetic Resonance Imaging and Autopsy Study , 2002, Stroke.

[74]  R. McKinstry,et al.  Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. , 2001, Radiology.

[75]  G. deVeber,et al.  Chickenpox and Stroke in Childhood: A Study of Frequency and Causation , 2001, Stroke.

[76]  F. Howe,et al.  Sensitivity of quantitative 1H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus , 2001 .

[77]  A. Hajeer,et al.  Visual Manifestations of Giant Cell Arteritis: Trends and Clinical Spectrum in 161 Patients , 2000, Medicine.

[78]  J. Petrella,et al.  Early diffusion-weighted MR imaging abnormalities in sustained seizure activity. , 2000, AJR. American journal of roentgenology.

[79]  R. Schiffmann,et al.  Profile of endothelial and leukocyte activation in fabry patients , 2000, Annals of neurology.

[80]  J. Mohr,et al.  The natural history of CADASIL: a pooled analysis of previously published cases. , 1999, Stroke.

[81]  N. Kocer,et al.  CNS involvement in neuro-Behçet syndrome: an MR study. , 1999, AJNR. American journal of neuroradiology.

[82]  D. D'cruz,et al.  Vasculitis in systemic lupus erythematosus , 1998, Lupus.

[83]  E. Gromnica-ihle,et al.  Color duplex ultrasonography in the diagnosis of temporal arteritis. , 1997, The New England journal of medicine.

[84]  T. Yoshimoto,et al.  Proton magnetic resonance spectroscopy in children with Moyamoya disease , 1997, Clinical Neurology and Neurosurgery.

[85]  J. Moodley,et al.  Single photon emission and cerebral computerized tomographic scan and transcranial Doppler sonographic findings in eclampsia , 1997, British journal of obstetrics and gynaecology.

[86]  J. Provenzale,et al.  Neuroradiologic findings in polyarteritis nodosa. , 1996, AJNR. American journal of neuroradiology.

[87]  P. N. Jayakumar,et al.  Cerebrovascular disease in children , 1994, Acta neurologica Scandinavica.

[88]  J. Hanly,et al.  Brain pathology in systemic lupus erythematosus. , 1992, The Journal of rheumatology.

[89]  E. Kansu,et al.  Vascular involvement in Behçet's disease. , 1992, The Journal of rheumatology.

[90]  M. Moskowitz,et al.  Contributions from the upper cervical dorsal roots and trigeminal ganglia to the feline circle of Willis. , 1989, Stroke.

[91]  R. Wiesner,et al.  Cyclosporin A-induced reversible cortical blindness. , 1988, Journal of clinical neuro-ophthalmology.

[92]  K. Tanaka,et al.  Histopathology of the brain vascular network in moyamoya disease. , 1983, Stroke.

[93]  A Takaku,et al.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. , 1969, Archives of neurology.